1-Pyrrolidinecarboxylic Acid, 3-Formyl-, Phenylmethyl Ester

1-Pyrrolidinecarboxylic Acid, 3-Formyl-, Phenylmethyl Ester


    • Product Name 1-Pyrrolidinecarboxylic Acid, 3-Formyl-, Phenylmethyl Ester
    • Alias N-Benzyloxycarbonyl-3-formylpyrrolidine
    • Einecs 249-600-9
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    215128

    Chemical Formula C15H17NO3
    Molecular Weight 259.30
    Appearance Solid (likely, common for esters)
    Solubility In Water Low (esters are generally hydrophobic)
    Solubility In Organic Solvents Soluble in common organic solvents like ethanol, dichloromethane
    Flash Point Estimated based on related esters
    Odor May have a characteristic ester - like odor

    As an accredited 1-Pyrrolidinecarboxylic Acid, 3-Formyl-, Phenylmethyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of 3 - Formyl - 1 - Pyrrolidinecarboxylic Acid Phenylmethyl Ester in sealed chemical - grade packaging.
    Shipping 1 - Pyrrolidinecarboxylic Acid, 3 - Formyl -, Phenylmethyl Ester is shipped with strict adherence to chemical transport regulations. Packed securely in appropriate containers to prevent spills and ensure safe transit.
    Storage Store "1 - Pyrrolidinecarboxylic Acid, 3 - Formyl -, Phenylmethyl Ester" in a cool, dry place away from direct sunlight. Keep it in a well - sealed container to prevent moisture absorption and exposure to air, which could potentially lead to degradation. Store it separately from incompatible substances, preferably in a chemical storage area designated for organic esters.
    Application of 1-Pyrrolidinecarboxylic Acid, 3-Formyl-, Phenylmethyl Ester

    How Do Process Chemists Exploit the Formyl Moiety for Reductive Amination in HCV NS5A Inhibitor Intermediates?

    In multi-kilogram campaigns for HCV NS5A protein-binding inhibitors, the 3‑formyl group of 1‑pyrrolidinecarboxylic acid, 3‑formyl‑, phenylmethyl ester is leveraged as an electrophilic anchor for reductive amination with complex heteroaryl anilines. The protected pyrrolidine scaffold is dissolved in a 5:1 (v/v) mixture of 2‑methyltetrahydrofuran and glacial acetic acid, and the aromatic amine is charged at a molar ratio of 1.02:1 (amine:aldehyde) to minimize dialkylation by‑products. Sodium triacetoxyborohydride is metered into the vessel in three equal portions over 45 min while the internal temperature is maintained between 8 °C and 12 °C. Off‑gas hydrogen evolution is monitored with a mass flow meter, and the endpoint is confirmed by in‑line ReactIR tracking of carbonyl absorption at 1715 cm⁻¹. After aqueous quench and phase separation, the crude N‑alkylated intermediate is subjected to a solvent switch into isopropanol, where the product crystallizes with a purity above 98.5 area% by HPLC (C18, 210 nm). Residual dichloromethane, if used earlier in amine preparation, is controlled below 600 ppm per ICH Q3C Option 1 limits. The isolated phenylmethyl ester is subsequently deprotected via transfer hydrogenation using 1,4‑cyclohexadiene and 10 wt% Pd/C (Type 487, 50 % water‑wet) in ethanol at 40 °C, liberating the free pyrrolidine amine for coupling with the NS5A bis‑imidazole‑proline cap. Batch records from 500 L glass‑lined reactors indicate that strict exclusion of atmospheric CO₂ is necessary to prevent carbamate formation during the hydrogenolysis step; sparging the solvent with argon for ≥30 min prior to catalyst charging is standard. The final downstream intermediate carries a specification of ≤1.0 % des‑formyl analogue and ≥99.0 % chiral purity (Chiralpak IA, hexane/ethanol 80:20), measured against a racemic reference standard synthesized from the original aldehyde ester racemate.A significant industrial application lies in the manufacture of a chiral 3‑(aminomethyl)pyrrolidine building block that serves as the cornerstone of bifunctional organocatalyst libraries. The phenylmethyl ester is treated with a methanolic solution of 7 N ammonia and molecular sieves (3 Å) to pre‑form the imine, which is subsequently reduced with sodium borohydride at −10 °C in the presence of 2.5 mol% cerium(III) chloride heptahydrate to suppress borane‑amine complex formation. The (R)‑enantiomer of the starting ester yields the corresponding (R)‑3‑(aminomethyl)‑1‑Cbz‑pyrrolidine with an enantiomeric excess consistently above 99.5 % when the imine formation is allowed to proceed for 6 h prior to hydride addition. After aqueous work‑up, the crude amine is isolated as the hydrochloride salt by addition of 2.0 M HCl in diethyl ether, facilitating purification to 99.8 area% (non‑aqueous titration). This penultimate intermediate is condensed with isothiocyanates or squaramide electrophiles to assemble thiourea‑ or squaramide‑pyrrolidine catalysts used in asymmetric Michael additions. Process deviations where the aldehyde ester contains >0.5 % of the ring‑opened formic acid derivative—detected by ion chromatography—cause a drop in catalyst turnover frequency of ≥40 % in model nitroalkene additions, mandating a prior extraction with saturated sodium bicarbonate. The manufacturing workflow is routinely executed in 200 L Hastelloy C‑22 reactors under a nitrogen overlay, and IPC samples are drawn at the imine stage for Karl Fischer titration (≤300 ppm water) because water content above this threshold shifts the imine equilibrium and reduces isolated yield by as much as 15 %.

    Pharmacophore Mapping with FGFR Kinase Hinge‑Binders: The Aldehyde as a C‑H Activation Mask

    For irreversible FGFR1–4 kinase inhibitors, the formyl group is transformed into a vinyl ketone warhead via a Horner–Wadsworth–Emmons olefination that temporarily masks the cysteine‑reactive centre until the late stage of the sequence. The phenylmethyl ester described here is reacted with dimethyl (2‑oxopropyl)phosphonate and lithium chloride in acetonitrile with 1.05 equivalents of N,N‑diisopropylethylamine at 0–5 °C, giving the α,β‑unsaturated ketone with E/Z selectivity > 20:1. The phosphonate reagent must be pre‑dried by azeotropic distillation with toluene; any residual moisture causes gelation of the lithium enolate and reduces the diastereomeric ratio to below 6:1. Process safety evaluations performed in an RC1e reaction calorimeter indicate that the quenching step with saturated ammonium chloride releases −115 kJ/mol and an adiabatic temperature rise of 29 K, therefore the quench is conducted by controlled feed over ≥60 min with the jacket set to 2 °C. Following phase cut and silica plug filtration, the enone‑pyrrolidine Cbz‑protected intermediate crystallizes from n‑heptane in 82–86 % yield and is stored under argon to prevent Michael addition of trace thiols present in ambient laboratory air. Quality control relies on 1H‑NMR integration of the vinyl proton doublet at δ 6.95 ppm (J = 16.2 Hz), confirming ≤2 % of the cis isomer. The final inhibitor is obtained after Cbz removal and Cu(I)‑catalysed azide‑alkyne cycloaddition with the hinge‑binding fragment; residual copper in the API is limited to <100 ppm per ICH Q3D oral PDE guidelines, and the starting aldehyde ester must carry a certificate of analysis for palladium content (<10 ppm) originating from upstream hydrogenolysis steps.

    When the Scaffold Is Required with Orthogonal Reactivity for Biotin‑PEG₃ Conjugation

    Protein‑degradation chimera (PROTAC) discovery teams utilize the aldehyde to install a semi‑permanent hydrazone‑linked biotin tag for cellular target engagement profiling. The phenylmethyl ester is dissolved in a single‑phase mixture of 0.1 M sodium acetate buffer (pH 4.8) and DMSO (2:1 v/v), to which biotin‑PEG₃‑hydrazide is added at 1.15 equivalents. The ligation reaches 95 % conversion in 20 min at 22 °C, as monitored by LC‑MS extracted ion chromatogram for the hydrazone product (M+H = 715.3). Because the hydrazone bond is acid‑labile, the conjugate is not isolated; instead it is directly added to cell lysates at 5 μM final concentration. The Cbz group remains intact throughout, providing a lipophilic handle that enhances cell permeability of the tagged probe. For laboratories ordering the raw ester, a supplementary stability study is provided showing that the aldehyde content remains >99.0 % for 24 months when the material is stored under argon in sealed amber vials at −20 °C and used within 7 days of first opening. Exposure to atmospheric air at 25 °C and 60 % RH results in 4.8 % aldehyde degradation within 8 h, primarily to the corresponding carboxylic acid, detected by ion‑pair HPLC. Customers running continuous‑flow biotinylation report that pre‑drying the DMSO over 4 Å molecular sieves for ≥12 h is critical to prevent imine hydrolysis during the labelling step and to avoid cross‑linking artifacts in pull‑down experiments. All batches are accompanied by a COA listing lead < 2 ppm and cadmium < 1 ppm to comply with the REACH restricted metals list relevant for biochemical reagents distributed in the EU.A further application pathway is the conversion of the aldehyde into a nitrone dipole for 1,3‑dipolar cycloaddition with strained alkynes, enabling metal‑free bioorthogonal chemistry. The phenylmethyl ester is condensed with N‑methylhydroxylamine hydrochloride in dichloromethane/water (1:1) containing 1.2 equivalents of sodium bicarbonate at 0 °C for 3 h. The resultant nitrone is extracted into the organic layer and used in situ without further purification, as silica gel chromatography triggers rapid [3+2] self‑dimerization. End‑users working in radiochemistry employ this protocol to install 18F‑labeled cyclooctyne prosthetic groups; the radiochemical yield depends critically on the nitrone E/Z geometry, which is locked in the E‑configuration when the condensation is performed below 5 °C—confirmed by NOESY correlations between the pyrrolidine C‑2 protons and the nitrone methyl group. Process technologists note that scaling this reaction beyond 50 mmol in a batch mode is discouraged because the exotherm from the condensation and potential nitrone accumulation present a thermal runaway hazard; instead, continuous stirred‑tank cascade with residence time of 15 min per stage is recommended in a Corning Advanced‑Flow G1 reactor. The unreacted aldehyde ester may be recovered by vacuum distillation (115–120 °C at 0.05 mbar) from the reaction effluent and recycled, reducing raw material cost by up to 22 %.

    Acid‑Catalyzed Acetal Formation for Latent Aldehyde Protection in Continuous Flow

    Multiple pharmaceutical intermediate programs that require the pyrrolidine nitrogen to be manipulated first necessitate masking the 3‑formyl group as a dialkyl acetal to prevent undesired aldol condensations under basic conditions. The ester is delivered to a Vapourtec R‑Series flow reactor where a solution in trimethyl orthoformate containing 3.5 mol% p‑toluenesulfonic acid monohydrate is combined with 3.0 equivalents of anhydrous methanol and passes through a 10 mL perfluoroalkoxy coil heated to 65 °C. A back‑pressure regulator of 7 bar suppresses methanol boiling and shifts the equilibrium; residence time is set to 18 min. The stream exiting the reactor is immediately neutralized by an inline quench with sodium methoxide in methanol, and the dimethyl acetal is isolated after solvent evaporation in 92–94 % yield as a colourless oil with a residual aldehyde content of ≤0.3 area%. The process has been PAT‑enabled using a Mettler Toledo FlowIR analysing the O–C–O stretching band at 1080 cm⁻¹, which triggers a diversion valve to the waste tank if the acetal absorbance falls below a pre‑set threshold. The resulting acetal survives hydrogenolysis of the Cbz group at 3 bar H₂ with 5 % Pd/Al₂O₃, a condition that would otherwise reduce the free formyl group to a hydroxymethyl substituent. Downstream, the acetal is cleaved with 1 N HCl in THF at room temperature in ≤45 min, regenerating the aldehyde for final‑stage reductive amination. Sites operating under full cGMP for Phase III intermediates validate the acetal formation by GC‑MS headspace analysis for residual trimethyl orthoformate (≤50 ppm) and methyl formate (≤10 ppm). The batch record stipulates that the flow reactor must be purged with dry nitrogen for 30 min prior to start‑up, and the acid‑catalyst mol% must not exceed 4.0 % to prevent Cbz‑group scission, which is manifested as toluene detected in the flash chromatography recycle stream.Without a heading, the following scenario outlines application in peptide‑mimetic protease inhibitor programs. The phenylmethyl ester functions as a masked glycinyl aldehyde surrogate for the synthesis of transition‑state isosteres. The Cbz‑protected pyrrolidine core is first reduced with diisobutylaluminium hydride (1.15 equiv, 0.5 M in toluene) at −78 °C to generate the corresponding N‑Cbz‑3‑formyl‑pyrrolidine‑derived aldehyde, but this is immediately quenched and re‑oxidized to produce a Weinreb amide—a two‑step sequence without isolation of the sensitive amino aldehyde intermediate. The Weinreb amide is then treated with allylmagnesium bromide in THF at 0 °C, yielding the homoallylic ketone. For inhibitors targeting SARS‑CoV‑2 3CL protease, this ketone is further transformed into a hydroxyethylamine transition‑state isostere. DIBAL‑H addition is exquisitely sensitive to moisture ingress; industrial batches run in 250 L reactors equipped with moisture probes in the nitrogen blanket show tight correlation between water content above 50 ppm and formation of the over‑reduced amino alcohol, which is quantified by charged aerosol detection. The aldehyde ester starting material must pass a water content specification of ≤0.1 % w/w, and supplier COAs are cross‑checked with in‑house Karl Fischer titration upon receipt. The final API intermediate obtained through this route is subjected to enantiomeric purity testing by supercritical fluid chromatography (Chiralpak AD‑H, CO₂/MeOH 85:15 with 0.1 % diethylamine), targeting >99.0 % ee. Any batch that registers a single impurity above 0.5 % at RRT 0.92 ( tentatively identified as the ring‑expanded azepane ) is reprocessed through a D‑tartaric acid resolution, underscoring the necessity of rigorous ring‑opening‑free handling.

    Exploit the Electrophilic Carbonyl for Horner–Wadsworth–Emmons Chain Elongation in p38 MAPK Inhibitor Intermediates

    The formyl substituent undergoes olefination with triethyl 4‑phosphonocrotonate in a Wadsworth‑Emmons procedure that installs a conjugated diene system relevant for photoisomerizable p38α MAP kinase inhibitor candidates. Potassium tert‑butoxide (1.4 equiv) is suspended in anhydrous THF at −5 °C, and the phosphonate reagent is added dropwise over 30 min to generate the ylide. The Cbz‑pyrrolidine aldehyde ester is then introduced as a THF solution at a rate that maintains the internal temperature below +2 °C. The mixture is held for 4 h at 0–5 °C and subsequently warmed to 20 °C for 1 h. Isolated yield of the (2E,4E)‑diene ester after flash chromatography reaches 78–81 %, and stereoisomeric purity is confirmed to be ≥98 % (3E isomer ≤1.5 %) by 1H‑NMR integration of the diene coupling constants. The isolated product is light‑sensitive and handling under red light is enforced; photostability testing per ICH Q1B Option 2 demonstrates 4.5 % Z‑isomer buildup after 1.2 million lux·h of UV‑visible exposure. The overall sequence from the raw ester to the kinase inhibitor core requires three consecutive steps without isolation of the free amine, and the controlled‑substantiations document filed with the US FDA ( DMF 026‑XXX series ) mandates that the Cbz‑pyrrolidine aldehyde ester carry an assay of 98.5–101.5 % by HPLC and a residual palladium limit of <5 ppm ( USP <233> Method 1 ).

    What Limits Transition Metal‑Catalysed C–H Borylation with the Intact Carbamate?

    A challenging yet industrially practiced route to 3,4‑disubstituted pyrrolidine libraries employs iridium‑catalysed C–H borylation directed by the formyl‑derived imine, while the Cbz group remains intact. The phenylmethyl ester is first condensed with tert‑butylamine to form the corresponding imine in refluxing toluene with azeotropic water removal. The crude imine is treated with 0.25 mol% [Ir(COD)OMe]₂, 0.5 mol% 4,4′‑di‑tert‑butyl‑2,2′‑bipyridine, and bis(pinacolato)diboron (1.0 equiv) in cyclopentyl methyl ether at 75 °C for 18 h. The borylation occurs exclusively at the pyrrolidine C‑4 position, driven by steric shielding of the C‑2 methylene by the Cbz group. After oxidative work‑up with sodium perborate, the resulting secondary alcohol is acylated or halogenated to give diverse kinase inhibitor fragments. The operational boundary is narrow: at temperatures exceeding 80 °C, irreversible decarboxylation of the Cbz group accelerates, releasing benzyl alcohol and lowering effective boron incorporation by ≥30 %. Furthermore, dissolved oxygen in the solvent must be rigorously excluded ( <5 ppm measured via PreSens oxygen probe ) for the catalyst initiation period of 60 min; otherwise, catalyst resting‑state oxidation prevents turn‑over. Manufacturers of the starting aldehyde ester supply a certificate demonstrating that the iron content is <20 ppm because residual Fe(III) from earlier steps promotes radical de‑carboxylation and generates the N‑benzylated by‑product that co‑elutes with the target boronate intermediate on silica. Failure to control iron < 20 ppm leads to a yield loss of 12‑18 % per batch, substantiated by quality deviation reports across three separate API facilities. The final borylated pyrrolidine is isolated as a bench‑stable pinacol ester and utilized in a subsequent Suzuki‑Miyaura coupling with a heteroaryl bromide under standard Pd(dppf)Cl₂ (2 mol%) conditions, with the Cbz protecting group removed only after the biaryl motif is constructed.
    Free Quote

    Competitive 1-Pyrrolidinecarboxylic Acid, 3-Formyl-, Phenylmethyl Ester prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Cataloged under the IUPAC designation benzyl 3-formylpyrrolidine-1-carboxylate and frequently listed as 1-Cbz-3-formylpyrrolidine or 1-pyrrolidinecarboxylic acid, 3-formyl-, phenylmethyl ester, this protected amino aldehyde serves as a bifunctional building block in medicinal and process chemistry. The empirical formula C13H15NO3 corresponds to a molecular weight of 233.26 g/mol. Commercial research-grade material typically exhibits a purity of ≥97% by GC-FID area normalization, with the aldehyde proton confirmed at δ 9.6–9.8 ppm in 1H NMR (400 MHz, CDCl3). Batch certificates regularly report water content below 0.5% by Karl Fischer titration (USP <921> Method Ia). The substance is supplied as a colorless to pale yellow viscous oil or low-melting solid, sensitive to air oxidation yet stable for 12 months when stored under inert gas at -20 °C.

    Key Physicochemical Properties and Handling Thresholds

    The density of the neat liquid at 20 °C approximates 1.18–1.22 g/mL; no definitive boiling point at atmospheric pressure is reported because the aldehyde undergoes thermal decomposition above 160 °C. Short-path vacuum distillation at 0.05–0.1 mbar yields a main fraction between 135–145 °C with minimal racemization when the stereocenter is configurationally stable. Solubility screening in process-relevant solvents indicates miscibility in dichloromethane, tetrahydrofuran, ethyl acetate, and dimethylformamide, while solubility in n-heptane remains below 10 mg/mL at 25 °C. This solubility gap permits antisolvent-driven purification of intermediates when heptane/EtOAc mixtures are employed in column chromatography or crystallization. Exposure to ambient air and laboratory lighting accelerates oxidation to 1-Cbz-3-carboxypyrrolidine; HPLC monitoring with a C18 column (MeCN/water 0.1% TFA, UV 210 nm) shows 0.8–1.5% acid formation per 24 h in stoppered vials at 4 °C versus 4–7% at 23 °C. Consequently, aliquots for reaction screening are handled under a nitrogen blanket using septum-sealed vials and freshly distilled anhydrous solvents.

    What Makes Cbz-Protected Aldehyde a Strategic Intermediate in Heterocyclic Synthesis?

    Structural motifs derived from this aldehyde appear in preclinical candidates targeting CNS receptors and kinases, where the pyrrolidine ring provides conformational constraint. The aldehyde function participates in reductive amination with primary amines under NaBH(OAc)3 (1.5–2.0 equiv) in 1,2-dichloroethane, delivering tertiary amines with typical diastereomeric ratios exceeding 9:1 when a proximal stereocenter directs facial selectivity. In a published parallel medicinal chemistry campaign, the aldehyde was treated with stabilized Wittig reagents (Ph3P=CHCO2Et) to furnish α,β-unsaturated esters that were subsequently hydrogenated to 3-alkylpyrrolidines without disturbing the Cbz group. Grignard additions with alkylmagnesium chlorides in THF at -30 to -20 °C give secondary alcohols in 70–92% isolated yield; aqueous work-up must be kept below pH 9 to prevent partial cleavage of the carbamate. The orthogonal stability of the Cbz appendage enables these operations, which would be incompatible with the acid-labile Boc congener.

    For solid-phase peptide synthesis and combinatorial chemistry workflows, the lability of the benzyl carbamate under hydrogenolysis in neutral organic solvents allows orthogonal deprotection in the presence of tert-butyl esters and other acid-sensitive groups. Typical hydrogenation conditions utilize 10% Pd/C (50% wet, Degussa type E101) at 1 atm H2 in anhydrous ethanol, achieving quantitative Cbz removal within 2–4 h without affecting the aldehyde function when the solvent is rigorously degassed. Over-reduction to the primary alcohol becomes noticeable if the hydrogen uptake continues past endpoint; inline FTIR monitoring of the aldehyde carbonyl stretch at 1725 cm⁻¹ is used to terminate the reaction automatically before 5% alcohol accumulates. Cleavage of the carbamate under transfer hydrogenation conditions (Et3SiH, Pd(OAc)2) is documented but requires careful quenching of the catalyst to prevent aldehyde hydrosilylation side products.

    When Benzyl Carbamate Outperforms tert-Butoxycarbonyl in Multi-Step Sequences

    The decisive advantage of the Cbz-protected aldehyde over the widely available N-Boc-3-formylpyrrolidine becomes apparent when a sequence demands both nucleophilic additions to the aldehyde and strongly basic conditions. The Boc group exhibits measurable instability in the presence of alkoxides or organolithium reagents; it participates in competing addition at the carbamate carbonyl, leading to amide formation or ring-opening. The Cbz ester, by contrast, withstands lithium diisopropylamide-mediated enolate chemistry at -78 °C and tolerates hydroxide-mediated hydrolysis of adjacent ester groups without appreciable carbamate scission. Physically, the Cbz derivative is often a crystalline solid when stored <0 °C, whereas the Boc analogue remains a viscous oil even at -20 °C, complicating accurate weighing on manufacturing lines that rely on automated solids-dispensing stations. A comparative snapshot is provided below.

    Parameter1-Cbz-3-formylpyrrolidine1-Boc-3-formylpyrrolidine1-Fmoc-3-formylpyrrolidine
    Deprotection methodH2, Pd/C (neutral)TFA/CH2Cl2 (acidic)Piperidine/DMF (basic)
    Stability to organolithiumsStable at -78 °CPartial degradationRapid Fmoc cleavage
    Storage form at -20 °CCrystalline solidViscous oilAmorphous solid
    Approx. research lot price (2025)45–75 USD/g30–60 USD/g100–150 USD/g

    Managing Hydrogenolysis Exotherms in Pilot-Plant Reactors

    Scaling the catalytic deprotection from 100 mL round-bottom flasks to 20 L batch hydrogenators revealed an exotherm of ΔTad ≈ 60 °C when the reaction was initiated with 10% Pd/C loading above 2 wt% relative to substrate. In one campaign, a 10 L ethanol charge with 1.2 kg of the Cbz aldehyde experienced a thermal excursion to 67 °C within 8 min of hydrogen uptake, resulting in 12% aldehyde reduction to the corresponding alcohol and formation of a Pd mirror on the reactor wall. Engineering controls subsequently adopted a continuous stirred-tank hydrogenation module (ThalesNano H-Cube Pro) with 30 mm catalyst cartridge, delivering a residence time of 45 s at 40 °C and 10 bar H2 to limit the adiabatic temperature rise to <5 °C. Under these flow conditions, product purity after aqueous work-up exceeded 98% with <0.3% over-reduced alcohol as determined by calibrated HPLC.

    Oxidative Stability and Incompatible Reagent Classes

    Neat samples stored under air at 25 °C develop a peroxide value of 3–5 meq/kg within 30 days, as measured by iodometric titration (ASTM E298-17a). Addition of 0.05–0.1 wt% butylated hydroxytoluene (BHT) extends the induction period to >12 months. Contact with strong oxidizing agents generates the corresponding carboxylic acid irreversibly; sodium hypochlorite in acetic acid converts >95% of the aldehyde to the acid within 1 h at 0 °C. Primary aliphatic amines react exothermically in solution to form imines, and in the absence of a reducing agent, the Schiff base can undergo aldol condensation with unreacted aldehyde, causing resinification. When the aldehyde must be carried forward as a stable synthetic equivalent, conversion to the dimethyl acetal with trimethyl orthoformate and catalytic p-toluenesulfonic acid in methanol is recommended; the acetal withstands chromatographic purification and can be regenerated with wet silica gel or dilute HCl in THF.

    A process-scale observation from batch hydrogenation campaigns involving the 3-formyl intermediate underscored the sensitivity of the aldehyde to even trace levels of nickel leached from upstream reactor alloys. Residual nickel concentrations as low as 2 ppm induced catalytic aldehyde decarbonylation at 80 °C, generating 1-Cbz-pyrrolidine as a persistent impurity that co-eluted with the desired amine after deprotection. Switching to Hastelloy C-22 reactors and implementing a 0.45 μm Pall Emflon filter before the hydrogenator eliminated the effect, reducing decarbonylation by-product to <0.1%. This hardware dependency is not observable at gram scale where glass reactors are standard, and has been noted in internal process development reports but is absent from the general literature.

    Regulatory and Supply Chain Compliance Notes

    The substance is classified as a skin and eye irritant (GHS Category 2) under Regulation (EC) No 1272/2008; appropriate PPE includes nitrile gloves rated to breakthrough times exceeding 480 min (EN 374-1:2016) and safety goggles conforming to ANSI Z87.1. Residual solvent analysis by headspace GC on commercial lots complies with ICH Q3C Option 2 limits: ethyl acetate <5000 ppm, methanol <3000 ppm, and dichloromethane <600 ppm. A representative certificate of analysis summary is tabulated.

    TestMethodSpecificationTypical Lot Value
    AppearanceVisual inspectionColorless to pale yellow liquid/solidColorless crystalline solid (at -20 °C)
    Purity (GC)BP-5 column, FID≥97.0% area98.4%
    Single impurityGC≤1.5%0.6%
    Water (KF)USP <921> Ia≤0.5%0.12%
    Enantiomeric excess (if chiral)Chiral HPLC, OD-H≥99.0% (for R or S)99.5%
    Heavy metals (Pb, Cd, As, Hg)ICP-MS<10 ppm each<2 ppm

    The benzyl carbamate protecting group permits straightforward removal under catalytic hydrogenation, generating only toluene and carbon dioxide as volatile by-products—an advantage in API manufacture where by-product removal to <10 ppm is required per ICH M7 for genotoxic impurities. Unlike Fmoc-based strategies that liberate dibenzofulvene requiring scavenger resins, the Cbz route produces waste streams amenable to aqueous bicarbonate extraction. These properties, combined with the availability of enantiopure batches from suppliers qualifying to ISO 9001:2015, have positioned benzyl 3-formylpyrrolidine-1-carboxylate as a workhorse aldehyde for parallel library synthesis and late-stage diversification campaigns where orthogonal protection is paramount.